{"id":"egg-based-influenza-vaccines","safety":{"commonSideEffects":[{"rate":"10-30","effect":"Injection site soreness or erythema"},{"rate":"5-15","effect":"Myalgia"},{"rate":"5-10","effect":"Headache"},{"rate":"1-5","effect":"Fever"},{"rate":"0.001-0.01","effect":"Guillain-Barré syndrome"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"These vaccines contain inactivated or attenuated influenza viruses that have been propagated in fertilized chicken eggs. The vaccine antigens trigger both humoral (antibody) and cell-mediated immune responses, enabling the body to recognize and neutralize circulating influenza viruses before infection occurs. This is a traditional vaccine platform that has been used for decades to provide seasonal protection against influenza.","oneSentence":"Egg-based influenza vaccines stimulate the immune system to produce antibodies and cellular immunity against influenza virus strains grown in embryonated chicken eggs.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:36:12.971Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Seasonal influenza prevention in adults and children"}]},"trialDetails":[{"nctId":"NCT05606965","phase":"PHASE2","title":"A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1010 in Healthy Adults","status":"COMPLETED","sponsor":"ModernaTX, Inc.","startDate":"2022-11-02","conditions":"Influenza","enrollment":172},{"nctId":"NCT03598439","phase":"PHASE4","title":"Randomized Influenza Vaccine Evaluation of Immune Response","status":"COMPLETED","sponsor":"Marshfield Clinic Research Foundation","startDate":"2018-07-30","conditions":"Influenza","enrollment":366},{"nctId":"NCT05479370","phase":"PHASE3","title":"Immunogenicity Trial of 3 Influenza Vaccines","status":"COMPLETED","sponsor":"Tan Tock Seng Hospital","startDate":"2022-09-29","conditions":"Influenza Vaccination","enrollment":366},{"nctId":"NCT05755620","phase":"PHASE1","title":"A Study to Evaluate the Safety and Immunogenicity of a Single Dose of H1ssF-3928 mRNA-LNP in Healthy Adults","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2023-04-05","conditions":"Influenza","enrollment":50},{"nctId":"NCT05513391","phase":"PHASE3","title":"Study With Quadrivalent Recombinant Influenza Vaccine (RIV4) Compared With Egg-Based Quadrivalent Influenza Vaccine (IIV4) in Participants Aged 3 to 8 Years","status":"TERMINATED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2022-11-10","conditions":"Influenza Immunization","enrollment":366},{"nctId":"NCT07126652","phase":"NA","title":"Serological Responses to Adjuvanted Versus Non-adjuvanted Influenza Vaccines Among People With HIV: a Randomized Clinical Trial","status":"NOT_YET_RECRUITING","sponsor":"National Taiwan University Hospital","startDate":"2025-10-01","conditions":"Antibody Response","enrollment":300},{"nctId":"NCT06054269","phase":"PHASE3","title":"Clinical Trial to Evaluate the Immunogenicity of an Adjuvanted Influenza Vaccine Among HCP","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centers for Disease Control and Prevention","startDate":"2022-11-04","conditions":"Influenza","enrollment":192},{"nctId":"NCT05514002","phase":"PHASE4","title":"Comparison of Recombinant Influenza Vaccine Versus Standard Egg-Based Inactivated Influenza Vaccine in Adults 18-64 Years","status":"TERMINATED","sponsor":"Fatimah Dawood","startDate":"2022-09-13","conditions":"Influenza, Human","enrollment":3988},{"nctId":"NCT03722589","phase":"PHASE4","title":"Immunogenicity Trial of Egg- Versus Non-Egg-Based Influenza Vaccines Among HCP","status":"COMPLETED","sponsor":"Centers for Disease Control and Prevention","startDate":"2018-09-12","conditions":"Influenza","enrollment":944},{"nctId":"NCT03734237","phase":"PHASE4","title":"A Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoD","status":"UNKNOWN","sponsor":"Henry M. Jackson Foundation for the Advancement of Military Medicine","startDate":"2018-11-06","conditions":"Influenza, Influenza-like Illness, Influenza Vaccines","enrollment":15449},{"nctId":"NCT04523324","phase":"PHASE4","title":"Immunogenicity Trial of Recombinant Influenza Vaccine Among HCP in Israel","status":"COMPLETED","sponsor":"Centers for Disease Control and Prevention","startDate":"2019-10-31","conditions":"Influenza","enrollment":577},{"nctId":"NCT01012557","phase":"NA","title":"H1N1v Vaccination of Pregnant Women: A Longitudinal Cohort Study Characterizing Influenza A H1N1v Vaccination in Pregnant Women","status":"COMPLETED","sponsor":"Copenhagen Studies on Asthma in Childhood","startDate":"2009-11","conditions":"H1N1v Influenza","enrollment":296},{"nctId":"NCT03893669","phase":"PHASE1","title":"Safety, Tolerability and Immunogenicity of an Trivalent Inactivated Cell-Culture Influenza Vaccine in Healthy Adults","status":"COMPLETED","sponsor":"SK Chemicals Co., Ltd.","startDate":"2012-09","conditions":"Prevention of Influenza","enrollment":100},{"nctId":"NCT03826719","phase":"PHASE1, PHASE2","title":"Safety, Tolerability and Immunogenicity of NBP607QIV in Healthy Adult Volunteers","status":"COMPLETED","sponsor":"SK Chemicals Co., Ltd.","startDate":"2014-02-17","conditions":"Influenza","enrollment":100},{"nctId":"NCT02600585","phase":"","title":"Post-Marketing Observational Study of Safety Following Vaccination With Flublok® Compared to Licensed IIV in Adults","status":"COMPLETED","sponsor":"Protein Sciences Corporation","startDate":"2015-11","conditions":"Human Influenza","enrollment":254648},{"nctId":"NCT00579345","phase":"PHASE3","title":"Second Extension Study to Evaluate Safety and Tolerability of Influenza Vaccines in Adults and Elderly, and to Evaluate Immunogenicity and Concomitant Vaccination With Pneumococcal Vaccine in a Subgroup","status":"COMPLETED","sponsor":"Novartis","startDate":"2007-10","conditions":"Influenza","enrollment":1522},{"nctId":"NCT00645411","phase":"PHASE2, PHASE3","title":"Pediatric Safety and Immunogenicity Study of Cell-Culture Derived and Egg-based Subunit Influenza Vaccines in Healthy Children and Adolescents","status":"COMPLETED","sponsor":"Novartis","startDate":"2007-10","conditions":"Influenza","enrollment":3604},{"nctId":"NCT01987011","phase":"PHASE3","title":"Phase III Study to Evaluate the Immunogenicity and Safety of MG1109 in Healthy Adult Volunteers","status":"COMPLETED","sponsor":"Green Cross Corporation","startDate":"2013-08","conditions":"Influenza","enrollment":420},{"nctId":"NCT01857206","phase":"PHASE3","title":"Safety of Two Trivalent Influenza Vaccines Evaluated in Children and Adolescents 4 to 17 Years of Age","status":"COMPLETED","sponsor":"Novartis Vaccines","startDate":"2013-05","conditions":"Influenza, Fever","enrollment":2055},{"nctId":"NCT01389466","phase":"PHASE1, PHASE2","title":"Study to Evaluate the Safety and Immunogenicity of MG1109 in Healthy Adult Volunteers","status":"COMPLETED","sponsor":"Green Cross Corporation","startDate":"2010-02","conditions":"Influenza","enrollment":346}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":44,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Egg based influenza vaccines","genericName":"Egg based influenza vaccines","companyName":"Henry M. Jackson Foundation for the Advancement of Military Medicine","companyId":"henry-m-jackson-foundation-for-the-advancement-of-military-medicine","modality":"Biologic","firstApprovalDate":"","aiSummary":"Egg-based influenza vaccines stimulate the immune system to produce antibodies and cellular immunity against influenza virus strains grown in embryonated chicken eggs. Used for Seasonal influenza prevention in adults and children.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}